Global Pharma Briefs: News from Viatris, Janssen, and CureVac
By

By
A roundup of news from Canada (Bausch Health Companies), Germany (CureVac, Janssen, BioMed X) and the US (Viatris, Biocon). Canada Bausch Health Completes $740-M Sale of Amoun Pharmaceuticals Bausch Health…

Pharma COVID Roundup: News from Novavax, Moderna, Lilly, Regeneron
By

By
The latest on COVID-19 vaccines/drugs and manufacturing from Novavax, Moderna, Lilly, Regeneron, CureVac, Glenmark, and the World Health Organization. Manufacturing and supply of COVID-19 vaccines and drugs EU To Purchase…

Lilly, Kumquat Biosciences in $2-Bn-Plus Small-Molecule Cancer Drug Pact
By

By
Eli Lilly and Company, through Loxo Oncology, a Lilly R&D group, and Kumquat Biosciences, a drug-discovery and development company, have entered into an exclusive collaboration to discover, develop, and commercialize…

Pharma COVID Roundup: News from Pfizer, Moderna, and AstraZeneca
By

By
The latest on COVID-19 vaccines/drugs and manufacturing from Pfizer, Moderna, AstraZeneca, J&J, Emergent BioSolutions, Sanofi, GSK, Vir Biotechnology, BI, Sinovac, and others. Manufacturing and supply of COVID-19 vaccines and drugs…

Global Pharma Briefs: News from AstraZeneca, Merck KGaA, and Viatris
By

By
A roundup of news from Africa (BioNTech), China (Merck KGaA) and the US (AstraZeneca, Regeneron, Viatris, Takeda, BlueRock Therapeutics, and others). Africa BioNTech in Project for mRNA Malaria Vaccine; Evaluates…

Global Pharma Briefs: News from J&J, Merck KGaA, and MorphoSys
By

By
A roundup of news from Australia (J&J), Germany (Merck KGaA, MorphoSys), Japan (Meiji, Dong-A ST, Intas Pharmaceuticals), and the US (J&J, Kyria Therapeutics). Australia J&J Extends Innovation Partnering Office in…

Pharma COVID Roundup: News from Moderna, Pfizer, Regeneron, and Takeda
By

By
The latest on COVID-19 vaccines/drugs and manufacturing from Moderna, Pfizer, Roche, Takeda, Regeneron Pharmaceuticals, and Sinovac. Manufacturing and supply of COVID-19 vaccines and drugs Takeda, Japan Gov’t Expand Supply Pact…

GSK Seeks to Sell Part of UK R&D Site for Proposed Campus for Start-ups
By

By
GlaxoSmithKline (GSK) is seeking to sell 33 acres of land from its R&D campus in Stevenage, UK to a private developer for a proposed life-science campus for biotechnology and early-stage…

Pharma COVID Roundup: News from J&J, Pfizer, Moderna, FDA
By

By
The latest on COVID-19 vaccines/drugs, manufacturing, and testing from J&J, Pfizer, BioNTech, Fosun, Sinovac, Sinopharm, and the FDA. Manufacturing and supply of COVID-19 vaccines and drugs FDA OKs Additional Batch…

Global Pharma Briefs: News from Sanofi, GSK, Pfizer, AbbVie, Biogen
By

By
A roundup of news from China (Sparx Therapeutics), France (Sanofi), the UK (Pfizer, AbbVie, and Biogen) and the US (GSK, Nkarta, and USP). China Sparx Therapeutics To Build for Antibody…